First Tracks Biotherapeutics, Inc. (TRAX) SEC filings
TRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 3, 2026
$46.56−0.54 (-1.15%)
Close on Nov 16, 2026Market cap $1.66BP/E –Yield –
SEC filings
12 of First Tracks Biotherapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 3, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 3, 2026 | Nov 3, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 19, 2026 | Oct 20, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 15, 2026 | Oct 15, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 12, 2026 | Oct 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 15, 2026 | Jun 22, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 20, 2026 | Apr 20, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 1, 2026 | Apr 3, 2026 | SEC EDGAR |
See a number that looks wrong?